60

DAFTAR PUSTAKA

Adams, K.F., Schatzkin, A., Harris, TB., Kipnis, V., Mouw, T., Barbash, R.B.,
Hollenbeck, A., Leitzmann, M.F., 2006. Overweight, Obesity, and Mortality in a
Large Prospective Cohort of Persons 50 to 71 Years Old. The New England
Journal of Medicine Vol. 355, No. 8: 763-778.
American Society for Aesthetic Plastic Surgery., 2003. National plastic surgery statistics:
cosmetic and reconstructive procedures trends (Internet). New York: American
Society for Aesthetic Plastic Surgery.
Anvisa (Agncia National de Vigilncia Sanitaria National Health Survailance Agency
Brazil)., 2003. Resolution No. 30 (Internet). Brazil: D.O.U.
Atkinson, RL., 2002. Medical evaluation of the obesitase patient. Dalam: Wadden TA
and Stunkard AJ. Eds. Handbook of Obesity Treatment. New York: The Guilford
Press, p173 185.
Available at:http://www.e-legis.bvs.br/leisref/public/show.Act.php?id=6847.
Anonym.

Available

at:

http://www.plasticsurgery.org/public_education//statistical-

trends.cfm.
Anonym. Available at : http:\\wikipedia.com
Barker, M. & Phillips, D.I.W., 2005. Fetal and infant origins of obesity. IN Kopelman,
P.G., Caterson, I.D & Dietz, W.H. (Eds) Clinical Obesity in Adults and Children.
2nd ed. Massachusetts, Blackwell Publishing Ltd.
Baumann. LS., 2003. Phosphatydilcholine. Skin Allergy News. 34:1.
Bellman.B., 2003. Phosphatydilcholine reaction. Skin Allergy News. 34:12.
Boyko. E J., 2000. Visceral adiposity and risk of tipe 2 diabetes: a prospective study
among Japanese Americans. Diabetes Care, Vol 23, 465-471.
Bray GA., 2007. The Metabolic Syndrome and Obesity. New Jersey: Humana Press.
Centers for Disease Control and Prevention (CDC)., 2005. Outbreak of mesotherapyassociated skin reactions District of Columbia area, January-February 2005.
MMWR Morb Mortal Wkly Rep 54(44): 1127-30.

61

Despres, J P., 2001. Treatment of Obesity: need to focus on high risk abdominally
obesitase patients. British Medical Journal, Vol 322, 716-720.
Despres., J P., 2001. Health consequences of visceral obesity. Annals of Medicine, Vol
33,:534-541
Diet, nutrition and the prevention of chronic diseases. Report of a joint WHO/FAO expert
consultation. Geneva, World Health Organization, 2003.
Dulloo, A., Jacquet, J. & Montani, J-P. (2002) Pathways from weight fluctuations to
metabolic diseases: focus on maladaptive thermogenesis during catch-up fat. Int J
Obesitas, 26, S46-S57.
Duncan D, Hasengschwandter F., 2005. Lipodissolve for subkutaneous fat reduction and
skin retraction. Aesthetic Surg J 25:530-43.
Dunn C., and Rollnick S., 2003. Lifestyle Change. London: Mosby.
Fabricatore A N and Wadden TA (2005) Lifestyle Modification in the Treatment of
Obesity, dalam The Management of Eating Disorders and Obesity (Goldstein DJ,
eds 2 nd). Human Press. New Jersey.
Gee M., Mahan LK and Escott-Stump S., 2008. Weight management. In: Mahan LK,
Escott-Stump S., eds. Krauses Food & Nutrition Therapy. 12th ed. St. Louis:
Saunders Elsevier, 532-562.
Goldman, R and Klatz. 2003. The New Anti-Aging Revolution. Australian Edition. P. 2224, 191-194.
Griffin, James E., & Sergio R. Ojeda., 2004. Textbook of Endocrine Physiologi. Oxford
University Press. USA.
Grundy SM., 2004. What is the contribution of obesity to the metabolic syndrome?
Endocrinol Metab Clin N Am, 33:267-82.
Gwartney, Dan, MD., 2005. Exercise and Fat Loss. Fitness Rx for Women. Oktober.
Hlm. 52-55.
Harman, D. 1982. Free Radical in Biology. Free radical theory of aging. Academic Press,
Orlando, V.(6).p.255-275.
Hasengschwandter F. Annual Lipodissolve Clinical Report (accessed May 2006)
Available from: www.network-lipolysis.com

62

Haslam, DW., James, WP., 2005. Obesity. Lancet ;366:1197-209.

Henry F, Pierard-Franchimont C, Pierard GE., [Clinical case of the month. Atypical
mycobacteria and mesotherapy]. Rev Med Liege 2005; 60 (1): 7-10.
Hexsel D, Serra M, Mazzuco R, DalForno T, Zechmeister D. Phosphatydilcholine in the
treatment of localized fat. J Drugs Dermatol 2003;2:511-8.
Hill, J.O (2006) Understanding and addressing the epidemic of obesity: an energy
balance. Endocrine reviews. 27, 750-761.
Hines, Dwayne II., April 2003. Fat Loss with Intensity Training. Fitness Rx for Women.
Hlm. 70-74.

Hofmekler, Ori & Mark Salzman., September 2003. Fat Burn Biology Part 1. Ironman.
Hlm. 114-121.
Available at : http:\\img.alibaba.com/photo/104574665/Lipostabil_N_Drugs.jpg

Kennedy, David. Big Fat. Muscle Media. May 2001. Hlm. 62-70.
Kleiner, Susan M,, PhD, RD, FACN, CNS. Calcium Diet. Fitness Rx for Women.
Oktober 2003. Hlm. 106-111.
Kopelman PG.,

Caterson I, and Dietz WH., 2005. Clinical Obesity in adults and

children, 2nd Ed, Blackwell Publishing.

Kusumawati, D. 2004. Bersahabat dengan Hewan Coba. Yogyakarta : Gajah Mada
University Press.
Leroy YV., 2003. The effect of Phosphatydilcholine on subkutaneoues fat. Aesthetic Surg
J;23:413-7.
Lieber CS., 2004. New concepts of the pathogenesis of alcoholic liver disease lead to
novel treatment. Curr Gastroenterol Rep; 6: 60-5.
Malole, Sri Utami Pramono, C. 1989. Penggunaan Hewan-hewan Percobaan di
Laboratorium. Jawa Barat: Institut Pertanian Bogor. Hal : 104 112.
Matarasso A, Pfeifer TM., 2005. Mesotherapy for body contouring. Plast Reconstr Surg
;115:1420-4.

63

Moy LS., 2004. Phosphatydilcholine injections. A study measuring decreased

subkutaneous fat thickness. American Society for Dermatologic Surgery and the
American Society of Mohs mocrographic surgery and cutaneous oncology
combined annual meeting, San Diego, CA, September 30 to October 3.
Nammi, S., Koka, S., Chinnala, K.M., and Boini, K.M., 2004. Obesity: An overview on
its current perspectives and treatment options. Nutr J, 3.
Natterman International GMBH. Lipostabil. Cologne, Germany: Natterman International,
1990, p. 9.
Newman, Cathy., August 2004. Why are We So fat?. National Geographic; Hlm. 46-61.
Ngatidjan, 2006. Metode Laboratorium dalam Toksikologi. Cetakan -1. Yogyakarta :
Bagian Farmakologi dan Tosikologi Fakultas Kedokteran UGM. Hal : 116, 136.
Obesity: preventing and managing global epidemic. Report of a WHO consultation.
Geneva, World Health Organization, 2000.
Ogden, C.L., Carroll, M.D., Curtin, L.R., McDowell, M.A., Tabak, C.J. & Flegal, K.M.
(2004) Prevalence of overweight and obesitasity in the United States. JAMA, 295,
1549-1555.
Pangkahila, W. 2007. Memperlamat Penuaan, Meningkatkan Kualitas Hidup.
Pischon, Boeing, Hoffmann, et al. General and abdominal adiposity and risk of death in
Europe. N Engl J Med 2008;359:2105-20
Preventing Chronic Diseases, a vital investment. Geneva, World Health Organization,
2005.
Rankinen, T., Zuberi, A., Changnon, Y.C., Weisnagel, J., Argyropoulos, G., Walts, B.,
Perusse, L. & Bouchard, C. (2006) The Human Obesity Gene Map: The 2005
Update. Obesity, 14, 529-644.
Rittes PG, Rittes JC, Carriel Amary MF., 2006. Injection of Phosphatydilcholine in fat
tissue: experimental study of local action in rabbits. Aesthetic Plast Surg; 30:4748.
Rittes PG., 2003. The use of Phosphatydilcholine for correction of localized fat deposits.
Aesthetic plast Surg;27:315-8.

64

Rittes PG., 2001. The use of Phosphatydilcholine for correction of lower lid bulging due
to prominent fat pads. Dermatol Surg;27;391-2.
Rohrich RJ., 2005. Mesotherapy: what is it? Does it work? Plast Reconstr Surg;115:1425.
Rose PT, Morgan M., 2005. Histological changes associated with mesotherapy for fat
dissolution. J Cosmet Laser Ther ;7:17-19.
Rotunda AM, Kolodney MS., 2006. Mesotheraphy and Phosphatydilcholine: historical
classification and review. Dermatol Surg; 32:465-80.
Salles AG, Valler CS, Ferreira MC., 2006. Histologic response to injected
Phosphatydilcholine in fat tissue: experimental study in a new rabbit model.
Aesthetic Plast Surg;30:479-84.
Snetselaar LG., 2008. Intervention: Counseling for change. In: Mahan LK, Escott-Stump
S., eds. Krauses Food & Nutrition Therapy. 12th ed. St. Louis: Saunders
Elsevier,: 489-506.
Soegih, R.. Wijaya, A., Sugondo, S & Heryanto. T. (2004) Estimating IMT and WC cut
off for obesitasity in Indonesia and health impact. In Tjokroprawiro, A., Soegih,
R., Sugondo, S., Wijaya, A., Sutaro, B., Tridjaja, B., Tambunan, V. & Hendarto,
A. (Eds) 3 rd Nationatl obesitasity symposium. Jakarta, ISSO.
The American Society for Aesthetic Plastic Surgery., 2004. Fat-melting fad: too good to
be true? (Internet). New York: American Society for Aesthetic Plastic Surgery,
Available at: http://www.surgery.org/press/news-release,php?iid=387.
The World Health Report 2002. Reducing risks, promoting healthy life. Geneva, World
Health Organization, 2002.
Victor S., 2003. Phosphatydilcholine works. Skin Allergy News;34:12.
Wiramihardja KK., 2004. Obesitas dan penanggulangannya.
Young VL., 2003. Lipostabil: the effect of Phosphatydilcholine on subkutaneous fat.
Aesthet Surg J;23:413-7.